White House Highlights The Leukemia & Lymphoma Society’s Efforts to Bring Clinical Trials and Treatment Innovation to Diverse and Underrepresented Communities Nationwide in Alignment with the Biden-Harris Administration's Cancer Moonshot

The Leukemia & Lymphoma Society (LLS), the largest nonprofit dedicated to creating a world without blood cancers, is proud to be recognized by the White House Cancer Moonshot for its investment and efforts to promote health equity in the latest Cancer Moonshot Fact Sheet released yesterday by the White House.

The ideal timing of this information from the White House during Blood Cancer Awareness Month is amplifying LLS’s dedication to ensuring that all blood cancer patients and survivors have access to the care they need, when they need it. But for too many patients, this does not happen. As demonstrated in the latest Cancer Moonshot Fact Sheet, LLS is making major investments in solutions to advance equitable access to care.

• Through the Influential Medicine Providing Access to Clinical Trials (IMPACT) program, LLS seeks to bring clinical trials to patients. The overall goal is to expand trial access by having clinical trial participation occur mainly at local community oncology centers.
• LLS’s Equity in Access Research Program aims to generate new evidence that can guide policy reform and changes in healthcare practice, in order to mitigate the impact of social, economic and environmental disadvantages and reduce barriers to care.

The programs highlighted are just two examples of many ways in which LLS is working to make a difference in the lives of those affected by blood cancer. In addition to investing in research, LLS also provides free, personalized support and advocates for policies at the state and federal levels that eliminate barriers to cancer care.

To read the entire announcement, please visit: https://www.lls.org/news/white-house-highlights-leukemia-lymphoma-societys-efforts-bring-clinical-trials-and-treatment